The Human Frontier Science Program (HFSP) is unique in supporting international collaboration to undertake innovative, risky, basic research at the frontier of the life sciences. The program is implemented by the International Human Frontier Science Program Organization (HFSPO). Since 1990, over 8000 researchers from more than 70 countries have been supported. Of these, 29 HFSP awardees have… Read more »
The Human Frontier Science Program (HFSP) is an international program of research support implemented by the International Human Frontier Science Program Organization (HFSPO). The HFSP promotes international collaboration in basic research focused on the elucidation of the sophisticated and complex mechanisms of living organisms. HFSP supports novel, innovative and interdisciplinary basic research focused on the complex mechanisms… Read more »
The Human Frontier Science Program (HFSP) is an international program of research support implemented by the International Human Frontier Science Program Organization (HFSPO). The HFSP promotes international collaboration in basic research focused on the elucidation of the sophisticated and complex mechanisms of living organisms. HFSP supports novel, innovative and interdisciplinary basic research focused on the complex mechanisms… Read more »
Mechanisms and measurement of disease progression in the early phase of neurodegenerative diseases Neurodegenerative diseases are debilitating and largely untreatable conditions that are strongly linked with age. Worldwide, there are estimated to be 50 million people with Alzheimer’s disease and related disorders, the most common group of neurodegenerative diseases. This figure is expected to double… Read more »
Mechanisms and measurement of disease progression in the early phase of neurodegenerative diseases Neurodegenerative diseases are debilitating and largely untreatable conditions that are strongly linked with age. Worldwide, there are estimated to be 50 million people with Alzheimer’s disease and related disorders, the most common group of neurodegenerative diseases. This figure is expected to double… Read more »
The Network Environments for Indigenous Health Research (NEIHR) Program has set the foundation towards establishing a national network of centres focused on capacity development, research and Knowledge Sharing (KS) centred on Indigenous Peoples (i.e., First Nations, Inuit and Métis). This funding opportunity is to support the renewal of the nine (9) originally funded NEIHR Centres… Read more »
Over the past few decades there have been remarkable advances in the prevention, diagnosis, treatment, and management of Sexually Transmitted and Blood-Borne Infections (STBBI), including HIV/AIDS, hepatitis B (HBV), hepatitis C (HCV), syphilis, chlamydia, gonorrhea, and human papilloma virus (HPV). By the end of 2020, Canada reported having met two of the three 90-90-90 global… Read more »
Over the past few decades there have been remarkable advances in the prevention, diagnosis, treatment, and management of Sexually Transmitted and Blood-Borne Infections (STBBI), including HIV/AIDS, hepatitis B (HBV), hepatitis C (HCV), syphilis, chlamydia, gonorrhea, and human papilloma virus (HPV). By the end of 2020, Canada reported having met two of the three 90-90-90 global… Read more »
Antimicrobial resistance (AMR) affects humans, animals and plants without geographic borders or species barriers. Progress on AMR is necessary to achieve the United Nations (UN) Sustainable Development Goals (SDGs), with AMR being deeply rooted into attainment of SDGs promoting no poverty, good health and wellbeing, zero hunger, reduced inequality, decent work and international growth. CIHR… Read more »
Antimicrobial resistance (AMR) affects humans, animals and plants without geographic borders or species barriers. Progress on AMR is necessary to achieve the United Nations (UN) Sustainable Development Goals (SDGs), with AMR being deeply rooted into attainment of SDGs promoting no poverty, good health and wellbeing, zero hunger, reduced inequality, decent work and international growth. CIHR… Read more »
Webinar CIHR will be hosting webinar(s) to support participants with the requirements of this funding opportunity and to answer questions. To find out more information and to register, visit the Webinars page. The goal of the CIHR Operating Grants: Knowledge Mobilization in Diabetes Prevention and Treatment is to enhance knowledge mobilization in the field of diabetes, focusing… Read more »
In Canada, sexually transmitted and blood-borne infections (STBBI) disproportionately affect several key populationsi and these disparities reflect the many and often intersecting systemic, biomedical, behavioural and social factors that influence STBBI acquisition, disease progression, access to care, effectiveness of interventions and, ultimately, health outcomes. Previous targeted investments specific to HIV/AIDS and hepatitis C research have helped… Read more »
Every year, the Chief Public Health Officer of Canada (CPHO) is mandated to provide the Minister of Health with an independent report on the state of public health in Canada. These reports seek to raise the profile of public health issues, stimulate dialogue and inform action to improve and protect the health of people living… Read more »
The Organization for the Study of Sex Differences (OSSD) is an international society composed of basic and clinical scientists of diverse backgrounds who aim to advance science from a sex and gender perspective. The CIHR Institute of Gender and Health (CIHR-IGH) will provide travel awards for trainees at Canadian institutions to attend the OSSD Meeting to be held on… Read more »
Heart & Stroke, along with the Canadian Institutes of Health Research-Institute of Gender and Health (IGH), is excited to announce the launch of a NEW funding competition, the Research Networks of Excellence in Women’s Heart and/or Brain Health. This funding competition will support the development of two (2) new research networks in Canada, dedicated to… Read more »
Heart & Stroke, along with the Canadian Institutes of Health Research-Institute of Gender and Health (IGH), is excited to announce the launch of a NEW funding competition, the Research Networks of Excellence in Women’s Heart and/or Brain Health. This funding competition will support the development of two (2) new research networks in Canada, dedicated to… Read more »
The CIHR Strategic Master’s Award program provides financial support to scholars who are engaged in an eligible master’s program in Canada (refer to Eligibility) and that are relevant to specific CIHR priority research areas. This support allows these scholars to concentrate on their studies in their chosen fields. The CIHR Strategic Master’s Award program is… Read more »
RIS will be offering support with application development for this opportunity. Prospective applicants are encouraged to contact Dr. Jennifer Stevens (v5js@mun.ca) or Dr. Amanda Crompton (ajcrompt@mun.ca) early during the development process to discuss the services available to them. The CIHR Strategic Plan recognizes the importance of building capacity and includes a focus on training the next generation of health… Read more »
RIS will be offering support with application development for this opportunity. Prospective applicants are encouraged to contact Dr. Jennifer Stevens (v5js@mun.ca) or Dr. Amanda Crompton (ajcrompt@mun.ca) early during the development process to discuss the services available to them. The CIHR Strategic Plan recognizes the importance of building capacity and includes a focus on training the next generation of health… Read more »
In 2018, Canada endorsed the WHO global health sector strategies to address HIV, viral hepatitis and sexually transmitted infections (STI), and established a Pan-Canadian Framework for Action for which success would be measured against the global targets to eliminate Sexually Transmitted and Blood-Borne Infections (STBBI) as a health concern by 2030. Accordingly, in 2018, CIHR expanded the scope… Read more »
In 2018, Canada endorsed the WHO global health sector strategies to address HIV, viral hepatitis and sexually transmitted infections (STI), and established a Pan-Canadian Framework for Action for which success would be measured against the global targets to eliminate Sexually Transmitted and Blood-Borne Infections (STBBI) as a health concern by 2030. Accordingly, in 2018, CIHR expanded the scope… Read more »
Are you an early career researcher, late-stage post-doctoral researcher, or research associate looking to pursue an academic career as an independent investigator? CIHR’s Institute of Infection and Immunity and HIV/AIDS and STBBI Research Initiative are pleased to announce the Spring 2024 New Investigator Forum (NIF), an event dedicated to supporting and promoting the professional development… Read more »
The current administrative coding system used in Canada, the International Classification of Diseases (ICD)-10-CA, only includes coding for a small fraction of the over 7000 known rare diseases. This prevents determination of the actual cost of diagnosis, care, and research of rare inherited diseases in Canada and impedes accurate estimation of the level of required… Read more »
In Canada, using current clinical diagnostic pathways, rare diseases (RDs) take an average of seven years to diagnose. This includes 2-3 misdiagnoses prior to the final correct diagnosis, with many specialist and subspecialist visits and much unnecessary testing. This diagnostic odyssey, along with social isolation, an absence of care coordination, and often high socioeconomic and… Read more »
The IHDCYH Talks Video Competition is a unique opportunity to submit a short video (5 minutes or less) that presents a clear evidence-based message to a lay audience that is designed to have an impact on the health of children, youth and families. This competition accepts video submissions from members of the research community, and… Read more »
CIHR is launching this funding opportunity (FO) to support the Canadian Brain Health and Cognitive Impairment in Aging Research Knowledge Mobilization (KM) Hub (herein referred to as “KM Hub”). This FO is a key part of the Brain Health and Cognitive Impairment in Aging (BHCIA) Research Initiative and the successful applicant team will be expected to collaborate… Read more »
CIHR is launching this funding opportunity (FO) to support the Canadian Brain Health and Cognitive Impairment in Aging Research Knowledge Mobilization (KM) Hub (herein referred to as “KM Hub”). This FO is a key part of the Brain Health and Cognitive Impairment in Aging (BHCIA) Research Initiative and the successful applicant team will be expected to collaborate… Read more »
The objective of the CAAIF/CIHR-III/CIHR-ICRH Food Allergy Research Grant is to fund a research grant focused on the area of food allergy research. VALUE OF THE AWARD There are three awards available for $100,000 each. One Award is designated for an early career researcher. One Award is designated for food allergy research in the context of circulatory and/or… Read more »
Rare diseases (RDs) constitute an under-recognized global health priority. In fact, notwithstanding their name, rare diseases are far from rare. The population prevalence of rare diseases is reported at 3.5-6.0% and they affect as many as 446 million people globally1. Of the 7,000 known rare diseases, only 5% have a treatment, with far fewer having… Read more »
Rare diseases (RDs) constitute an under-recognized global health priority. In fact, notwithstanding their name, rare diseases are far from rare. The population prevalence of rare diseases is reported at 3.5-6.0% and they affect as many as 446 million people globally1. Of the 7,000 known rare diseases, only 5% have a treatment, with far fewer having… Read more »
The Clinical Trials Fund (CTF) is an integral part of Canada’s Biomanufacturing and Life Sciences Strategy (BLSS). In 2022, CIHR launched three CTF funding opportunities that provided up to three years of funding for: a pan-Canadian clinical trials consortium to provide a coordination infrastructure; training platforms aimed at developing the skills of highly qualified personnel (HQP) to design, conduct… Read more »
The Clinical Trials Fund (CTF) is an integral part of Canada’s Biomanufacturing and Life Sciences Strategy (BLSS). In 2022, CIHR launched three CTF funding opportunities that provided up to three years of funding for: a pan-Canadian clinical trials consortium to provide a coordination infrastructure; training platforms aimed at developing the skills of highly qualified personnel (HQP) to design, conduct… Read more »
Inequities persist in Canada’s health system, from research to care. Women are more likely to die of preventable illnesses and bear a higher burden of chronic illnesses. Significant health inequities and barriers to care also are experienced by Indigenous Peoples (First Nations, Inuit, and Métis), Black people, racialized people, sexually and gender diverse people, immigrants,… Read more »
Inequities persist in Canada’s health system, from research to care. Women are more likely to die of preventable illnesses and bear a higher burden of chronic illnesses. Significant health inequities and barriers to care also are experienced by Indigenous Peoples (First Nations, Inuit, and Métis), Black people, racialized people, sexually and gender diverse people, immigrants,… Read more »
About the CIHR Network Environments for Indigenous Health Research (NEIHR) Initiative This funding opportunity is one of several planned as part of the NEIHR Program. In 2019, CIHR funded nine (9) NEIHR Centres based in the following regions: Atlantic, Quebec, Ontario, Manitoba, Saskatchewan, Alberta, British Columbia, Nunavut and the Northwest Territories. CIHR is now looking… Read more »
The majority of Canadians partake in some form of gambling, and for some, this can lead to the development of problematic gambling behaviours and even gambling disorder. This is associated not only with financial loss, but also with effects on the physical and/or mental health of the individual. The recent increase of gambling advertising, the… Read more »
The majority of Canadians partake in some form of gambling, and for some, this can lead to the development of problematic gambling behaviours and even gambling disorder. This is associated not only with financial loss, but also with effects on the physical and/or mental health of the individual. The recent increase of gambling advertising, the… Read more »
CIHR-ICRH is proud to support the Team Grant: Lung Health funding opportunity! The goal of this investment is to unite interdisciplinary research teams to address threats to lung health while leveraging past investments, existing capacity, available infrastructure, and research expertise. The purpose of the Team Grant funding opportunity is to fund interdisciplinary teams that will… Read more »
Please note: To be eligible for application an EOI must be completed. RIS will be offering support with application development for this opportunity. Prospective applicants are encouraged to contact Dr. Jennifer Stevens (v5js@mun.ca) or Dr. Amanda Crompton (ajcrompt@mun.ca) early during the development process to discuss the services available to them. Rare Diseases (RDs) constitute an… Read more »
Please note: To be eligible for application an EOI must be completed. RIS will be offering support with application development for this opportunity. Prospective applicants are encouraged to contact Dr. Jennifer Stevens (v5js@mun.ca) or Dr. Amanda Crompton (ajcrompt@mun.ca) early during the development process to discuss the services available to them. Rare Diseases (RDs) constitute an… Read more »
Please note: The Memorial Deadline for this competition has been extended by an additional day to accommodate Labour Day Break (September 4, 2023). GRANT OBJECTIVE The objective of the CAAIF/CIHR-III Food Allergy Research Grant is to fund a research grant focused on the area of food allergy research. VALUE OF THE AWARD There are two awards available… Read more »
Nominators are advised to contact Ellen Steinhauer, Awards and Honours, for information on these competitions. The CIHR Gold Leaf Prizes are among the highest honours that can be bestowed on an individual or team for excellence in health research and its translation into benefits for Canadians. Each CIHR Gold Leaf Prize has a value of $100,000…. Read more »
Please note: The Memorial Deadline has been extended by an additional day to accommodate Mid-July holiday. The goal of this Funding Opportunity (FO) is to advance the understanding about risk reduction and protective factors involved in promoting cognitive health and mitigating the changes that occur in the onset and progression of cognitive impairment and dementia… Read more »
The goal of this Funding Opportunity (FO) is to advance the understanding about risk reduction and protective factors involved in promoting cognitive health and mitigating the changes that occur in the onset and progression of cognitive impairment and dementia in aging, while considering the intersection of different factors, including the social determinants of health and… Read more »
RIS will be offering support with application development for this opportunity. Prospective applicants are encouraged to contact Dr. Jennifer Stevens (v5js@mun.ca) early during the development process to discuss the services available to them NOTE: This competition is by invitation only. Only researchers who have previously submitted an LOI can be invited. A state of prolonged… Read more »
Please note: Instructions on how to apply are now available on ResearchNet, here. RIS will be offering support with application development for this opportunity. Prospective applicants are encouraged to contact Dr. Jennifer Stevens (v5js@mun.ca) early during the development process to discuss the services available to them. CIHR and the International Development Research Centre (IDRC) are… Read more »
The CIHR HIV/AIDS and Sexually Transmitted and Blood-Borne Infections (STBBI) Community-Based Research (CBR) Program (hereafter referred to as the CBR Program) is one of four research funding areas of the CIHR HIV/AIDS and STBBI Research Initiative, and supports the mission to strengthen and support a diverse, inclusive and collaborative research community that applies community-based, holistic and inter- and… Read more »
RIS will be offering support with application development for this opportunity. Prospective applicants are encouraged to contact Dr. Jennifer Stevens (v5js@mun.ca) early during the development process to discuss the services available to them. The Transforming Health with Integrated Care (THINC) Knowledge Mobilization & Impact Hub (herein called the THINC Impact Hub or Hub) is a… Read more »
CIHR’s Strategic Plan 2021-2031 commits to 1) maximizing results for Canadians by prioritizing the dissemination and implementation of existing knowledge to inform health practice and policy and enhance health equity; and 2) improving the health literacy of Canadians and empowering them to take charge of their own health. Through this Café Scientifique funding opportunity, CIHR will… Read more »
*Please contact RIS for guidance on deadlines for this opportunity. RIS will be offering support with application development for this opportunity. Prospective applicants are encouraged to contact Dr. Jennifer Stevens (v5js@mun.ca) early during the development process to discuss the services available to them. Please note: Instructions on how to apply are now available on ResearchNet,… Read more »
The Government of Canada introduced new funding through the Research Support Fund (RSF) in Budget 2022 to further support the activities related to the indirect costs of research security and to support the National Security Guidelines for Research Partnerships. The funding will be added as a new priority area of the Incremental Project Grants to… Read more »
RIS will be offering support with application development for this opportunity. Prospective applicants are encouraged to contact Dr. Jennifer Stevens (v5js@mun.ca) early during the development process to discuss the services available to them A state of prolonged inflammation has been associated with many chronic health conditions, including but not limited to cancer, diabetes, metabolic syndrome,… Read more »
RIS will be offering support with application development for this opportunity. Prospective applicants are encouraged to contact Dr. Jennifer Stevens (v5js@mun.ca) early during the development process to discuss the services available to them Approximately 300,000 Canadians live with type 1 diabetes (T1D), and the incidence of T1D in children in Canada is among the highest… Read more »
Existing since March of 2001, Brain Star is a program of CIHR’s Institute of Neurosciences Mental Health and Addiction (CIHR-INMHA). Brain Star is administered under the Institute Community Support Grants and Awards program and is designed to recognize the excellence of research done in Canada by students and trainees in all fields and disciplines covered by CIHR-INMHA. The specific objectives of the Brain Star program… Read more »
Antimicrobial resistance (AMR) is a critical and growing global public threat that requires a unified global response for human, animal and environmental health. The World Health Organization (WHO) has warned that AMR threatens to reverse a century of medical progress and governments and health organizations around the world are paying increasingly more attention. Successfully addressing… Read more »
*Please contact RIS for guidance on deadlines for this opportunity. Approximately 300,000 Canadians live with type 1 diabetes (T1D), and the incidence of T1D in children in Canada is among the highest in the world. In Canada, around 25-45% of new pediatric T1D diagnoses in the general population present with the life-threatening complication of diabetic… Read more »
Inequities persist in Canada’s health system, from research to care. Women are more likely to die of preventable illnesses and bear a higher burden of chronic illnesses. Significant health inequities and barriers to care also are experienced by Indigenous Peoples (First Nations, Inuit, Métis, and urban Indigenous communities), Black people, racialized people, sexually and gender… Read more »
GRANT OBJECTIVE The objective of the Allergic Airways Disease Innovation Grant is to fund innovative research of a “high-risk, high-reward” nature that will have impact on the prevention or treatment of allergic airways disease. VALUE OF THE AWARDS There are three awards available for a maximum value of $85,000 each. DURATION The Innovation Grant is for one… Read more »
Important Dates Competition 202302JCI Registration Deadline 2023-01-17 Application Deadline 2023-02-16 Anticipated Notice of Decision 2023-08-08 Funding Start Date 2023-11-01 Phase II of the Joint Canada-Israel Health Research Program (the Program) seeks to support cutting-edge research in the biomedical sciences and global health. This second call for proposals under Phase II is directed toward applicants conducting research in… Read more »
*Please contact RIS for guidance on deadlines for this opportunity. Important Dates Competition 202302JCI Registration Deadline 2023-01-17 Application Deadline 2023-02-16 Anticipated Notice of Decision 2023-08-08 Funding Start Date 2023-11-01 Phase II of the Joint Canada-Israel Health Research Program (the Program) seeks to support cutting-edge research in the biomedical sciences and global health. This second call for proposals… Read more »
RIS will be offering support with application development for this opportunity. Prospective applicants are encouraged to contact Jennifer Stevens (v5js@mun.ca) early during the development process to discuss the services available to them. CIHR-ICRH in partnership with Mitacs is excited to announce a funding opportunity for the Sleep Research Consortium – Research Team. The purpose of… Read more »
RIS will be offering support with application development for this opportunity. Prospective applicants are encouraged to contact Jennifer Stevens (v5js@mun.ca) early during the development process to discuss the services available to them. CIHR-ICRH in partnership with Mitacs is excited to announce a funding opportunity for the Sleep Research Consortium – Research Team. The purpose of… Read more »
Research has shown an increasingly clear relationship between diabetes (both type 1 [T1D] and type 2 diabetes [T2D]) and a variety of psychosocial factors. Psychosocial factors are defined as complex environmental, social, behavioural, and emotional factors and these can influence living well with diabetes, achieving satisfactory diabetes-related medical outcomes and psychological well-being (1). Diabetes has… Read more »
The CIHR Institute of Nutrition, Metabolism and Diabetes (INMD) supports research to enhance health in relation to diet, digestion, excretion, and metabolism; and to address causes, prevention, screening, diagnosis, treatment, support systems, and palliation for a wide range of conditions and problems associated with hormone, digestive system, kidney, and liver function. For information about INMD,… Read more »
Applications accepted on an ongoing basis until November 1, 2022 INMD supports research to enhance health in relation to diet, digestion, excretion, and metabolism; and to address causes, prevention, screening, diagnosis, treatment, support systems, and palliation for a wide range of conditions and problems associated with hormone, digestive system, kidney, and liver function. The INMD… Read more »
The Government of Canada has announced special funding, in the form of supplements to existing research grants, that will provide relief and assistance to research trainees from Ukraine. The Special Response Fund for Trainees (Ukraine) is administered by Canada’s three federal research funding agencies – the Canadian Institutes of Health Research (CIHR), the Natural Sciences and Engineering… Read more »
The CGEn HostSeq/CIHR Joint Postdoctoral Fellowship Program will support highly-qualified postdoctoral trainees whose research involves the study of human genetics and the challenges of COVID-19 disease in Canada using bioinformatic approaches. Successful applicants to the Fellowship Program must apply for access to and use CGEn’s host genome sequencing (HostSeq) Databank to support their postdoctoral research… Read more »
Precision medicine is an important “approach for disease treatment and prevention that takes into account individual variability in genes, environment, and lifestyle”1. Often described as the provision of the right treatment for the right patient at the right time, precision medicine focuses on integrating multidimensional data about genetic, molecular, and environmental factors to improve disease… Read more »
Precision medicine is an important “approach for disease treatment and prevention that takes into account individual variability in genes, environment, and lifestyle”1. Often described as the provision of the right treatment for the right patient at the right time, precision medicine focuses on integrating multidimensional data about genetic, molecular, and environmental factors to improve disease… Read more »
The Canadian Drug and Substances Strategy (CDSS) is the Government of Canada’s comprehensive, collaborative, compassionate, and evidence based approach to addressing drug and substance policy including innovative approaches to treatment and harm reduction. The current funding opportunity will expand the evidence base around psilocybin-assisted psychotherapy to inform practical policies and regulations that aim to improve… Read more »
The Canadian Drug and Substances Strategy (CDSS) is the Government of Canada’s comprehensive, collaborative, compassionate, and evidence based approach to addressing drug and substance policy including innovative approaches to treatment and harm reduction. The current funding opportunity will expand the evidence base around psilocybin-assisted psychotherapy to inform practical policies and regulations that aim to improve… Read more »
The 2021 Federal Budget announced funding for CIHR’s Clinical Trials Fund (CTF), an integral component of Canada’s Biomanufacturing and Life Sciences Strategy (BLSS). In support of this, the CTF will provide funding through three specific vehicles: platforms with the development of a pan-Canadian Clinical Trials Consortium; people with the funding of training platforms; and, projects through the funding of… Read more »
The 2021 Federal Budget announced funding for CIHR’s Clinical Trials Fund (CTF), an integral component of Canada’s Biomanufacturing and Life Sciences Strategy (BLSS). In support of this, the CTF will provide funding through three specific vehicles: platforms with the development of a pan-Canadian Clinical Trials Consortium; people with the funding of training platforms; and, projects through the funding of… Read more »
RIS will be offering support with application development for this opportunity. Prospective applicants are encouraged to contact Jennifer Stevens (v5js@mun.ca) early during the development process to discuss the services available to them. The Strategy for Patient-Oriented Research (SPOR) is a national coalition of federal, provincial and territorial partners, including patients (a term inclusive of individuals with personal… Read more »
CIHR will schedule a collaboration call with those who submitted an LOI, on May 30th, 2022, to explore collaborations across teams. It is mandatory for all Nominated Principal Applicants (NPAs) who submitted an LOI to attend this call. Linkage Tool CIHR is providing a linkage tool that is intended to facilitate connections and collaborations (domestically… Read more »
CIHR will schedule a collaboration call with those who submitted an LOI, on May 30th, 2022, to explore collaborations across teams. It is mandatory for all Nominated Principal Applicants (NPAs) who submitted an LOI to attend this call. Linkage Tool CIHR is providing a linkage tool that is intended to facilitate connections and collaborations (domestically… Read more »
CIHR is pleased to provide this pre-announcement of the Clinical Trials Fund (CTF) in order to allow the research community time to prepare and respond to what will be an expedited process. This $250 million funding opportunity over 3 years stems from 2021 Federal Budget announcements and in the first phase, is an integral component of Canada’s Biomanufacturing… Read more »
Non-communicable diseases (NCDs) are responsible for more than 60% of deaths globally, and 80% of NCD deaths occur in countries that have experienced rapid changes in population demographics (over 2 to 4 generations) and environments, including urbanization, lifestyle changes and changes in diet1. To address these issues, CIHR developed Healthy Life Trajectories Initiative (HeLTI), which follows… Read more »
Causative genes for human genetic disease are now being discovered at a remarkable rate. In some cases, these genes have well-known functions, but in many other cases they have not been the subject of much previous study and little or nothing is known about their function. As recognized in International Rare Diseases Research Consortium’s (IRDiRC)… Read more »
Background Every year in Canada there are nearly 1000 children diagnosed with cancer. It is the most common disease-related cause of death among Canadian children – more than asthma, diabetes, cystic fibrosis and AIDS combined. Although survival rates for many of the most commonly diagnosed cancers in children and youth continue to improve, it is… Read more »
The CIHR HIV/AIDS and Sexually Transmitted and Blood-Borne Infections (STBBI) Community-Based Research (CBR) Program (hereafter referred to as the CBR Program) is one of four research funding areas of the CIHR HIV/AIDS and STBBI Research Initiative. The CIHR HIV/AIDS and STBBI Research Initiative is responsible for the research components of the Government of Canada’s initiatives to address HIV/AIDS… Read more »
This funding opportunity is part of the Government of Canada’s continued response to address the health challenges of the COVID-19 pandemic. The SARS-Co-V2 (COVID-19) pandemic has had dramatic effects on children and families in Canada. School closures, parental work from home measures, virtual classroom learning and the effects of COVID-19 infections in children (e.g., myocarditis, multisystem inflammatory… Read more »
GACD call for applications: A life course approach to common NCD risk factor prevention and reduction This funding opportunity is part of the seventh call for applications of the Global Alliance for Chronic Diseases (GACD). Established in 2009, the GACD is an alliance of 12 of the largest public funders of health research from around the world…. Read more »
PRE-ANNOUNCEMENT Notice of upcoming COVID-19 research funding opportunity CIHR would like to provide information to the research community on an upcoming rapid funding opportunity that is part of the Government of Canada’s continued response to address the health challenges of the COVID-19 pandemic. The Operating Grant: Canadian Pediatric (Hospital) COVID Vaccination Platform competition will launch… Read more »
Important Dates Competition 202203OBH Registration Deadline 2022-02-22 Application Deadline 2022-03-08 Anticipated Notice of Decision 2022-06-28 Funding Start Date 2022-07-01 This funding opportunity will provide support for the creation of two networks: one in the priority area of Oral Health and one in the priority area of Bone Health. The aim of these networks will be… Read more »
Important Dates Competition 202203OBH Registration Deadline 2022-02-22 Application Deadline 2022-03-08 Anticipated Notice of Decision 2022-06-28 Funding Start Date 2022-07-01 This funding opportunity will provide support for the creation of two networks: one in the priority area of Oral Health and one in the priority area of Bone Health. The aim of these networks will be… Read more »
The CTN Postdoctoral Fellowship Awards Program facilitates research in HIV, hepatitis C (HCV) and other sexually transmitted and blood-borne infections (STBBIs) and related health conditions by providing funding to candidates who wish to write a trial protocol, research program, and develop and run their own trial. Each award is worth $50,000 plus up to $5,000… Read more »
SIRI will be offering support with application development for this opportunity. Prospective applicants are encouraged to contact Jennifer Stevens (v5js@mun.ca) early during the development process to discuss the services available to them. The focus of Transitions in Care (TiC) Team Grants Phase 2 is to support inter-disciplinary teams that are poised and ready to optimize… Read more »
The goal of the Race, Gender and Diversity Initiative is to support community-based and community-led research partnerships with postsecondary institutions that are grounded in the lived experience of underrepresented or disadvantaged groups and that analyze the causes and persistence of systemic racism and discrimination. Leadership by people from underrepresented or disadvantaged groups in research projects… Read more »
This funding opportunity is part of Government of Canada’s continued response to address the health challenges of the COVID-19 pandemic. During the COVID-19 pandemic, domestic and international organizations (e.g. Public Health Agency of Canada, Health Canada, United States National Institutes of Health, and World Health Organization) have played critical roles in providing guidance, sharing data… Read more »
This funding opportunity is part of Government of Canada’s continued response to address the health challenges of the COVID-19 pandemic. During the COVID-19 pandemic, domestic and international organizations (e.g. Public Health Agency of Canada, Health Canada, United States National Institutes of Health, and World Health Organization) have played critical roles in providing guidance, sharing data… Read more »
SIRI will be offering support with application development for this opportunity. Prospective applicants are encouraged to contact Jennifer Stevens (v5js@mun.ca) early during the development process to discuss the services available to them. The purpose of this funding opportunity is to support a Sleep Research Consortium focused on sleep hygiene and insomnia through the lifecycle. The… Read more »
SIRI will be offering support with application development for this opportunity. Prospective applicants are encouraged to contact Jennifer Stevens (v5js@mun.ca) early during the development process to discuss the services available to them. The purpose of this funding opportunity is to support a Sleep Research Consortium focused on sleep hygiene and insomnia through the lifecycle. The… Read more »
Vaccination is one of the most effective prophylactic interventions in the history of public health. Widespread vaccine uptake has eradicated smallpox worldwide, and eliminated polio, measles, rubella, and congenital rubella syndrome in the Americas. Despite these historic successes, in 2019, the World Health Organization declared vaccine hesitancy as one of the top ten global health… Read more »
As the COVID-19 pandemic has grown and progressed, globally as well as in Canada, the focus of much of the mitigation measures, including research, public health and policy, has been on dealing with the immediate crisis associated with infection and spread of the SARS-CoV2 virus, and implementing measures designed to impede the spread of the… Read more »
The Canadian Cancer Society (CCS), the Canadian Institutes of Health Research – Institute of Cancer Research (CIHR-ICR), the Canadian Institutes of Health Research-Institute of Indigenous Peoples’ Health (CIHR-IIPH), and partners have committed approximately $5M over one year to jointly fund up to 25 Proof-of-Concept Grants focused on interventions in Primary Cancer Prevention. The long-term objective… Read more »
The Canadian Cancer Society (CCS), the Canadian Institutes of Health Research – Institute of Cancer Research (CIHR-ICR), the Canadian Institutes of Health Research-Institute of Indigenous Peoples’ Health (CIHR-IIPH), and partners have committed approximately $5M over one year to jointly fund up to 25 Proof-of-Concept Grants focused on interventions in Primary Cancer Prevention. The long-term objective… Read more »
SIRI will be offering support with application development for this opportunity. Prospective applicants are encouraged to contact Jennifer Stevens (v5js@mun.ca) early during the development process to discuss the services available to them. Heart failure (HF) is a chronic, progressive and multifactorial condition where the heart is unable to pump sufficient blood to meet the body’s… Read more »
SIRI will be offering support with application development for this opportunity. Prospective applicants are encouraged to contact Jennifer Stevens (v5js@mun.ca) early during the development process to discuss the services available to them. Heart failure (HF) is a chronic, progressive and multifactorial condition where the heart is unable to pump sufficient blood to meet the body’s… Read more »
Timelines: To minimize gaps in funding when transitioning from Phase 1 to Phase 2, applicants must carefully review the program deadlines below to understand which deadline is most applicable to their situation considering their Phase 1 Award end date and their desired Phase 2 Award start date. Awardees must consider the following information: The start dates below are currently… Read more »